PCVX: Vaxcyte, Inc. Stock

by  •  • Comments Off on PCVX: Vaxcyte, Inc. Stock

SIC 2836 – Biological Products, Except Diagnostic Substances (Biotech)

Valuation
Market Cap ($M) 6,603.87
Enterprise Value ($M) 6,206.42
Book Value ($M) 1,240.47
Book Value / Share 11.41
Price / Book 5.32
NCAV ($M) 928.50
NCAV / Share 8.54
Price / NCAV 7.11

Profitability (mra)
Return on Invested Capital (ROIC) -0.32
Return on Assets (ROA) -0.40
Return on Equity (ROE) -0.43

Liquidity (mrq)
Quick Ratio 7.54
Current Ratio 7.54

Balance Sheet (mrq) ($M)
Current Assets 1,095.95
Assets 1,407.92
Liabilities 167.45
Debt n/a
Equity n/a

Income Statement (mra) ($M)
Revenue 0.00
Operating Income -468.04
Net Income -402.27

Cash Flow Statement (mra) ($M)
Cash From Operations -296.79
Cash from Investing -773.31
Cash from Financing 639.81

(click for more detail)

File Date Form Activist 13D/G Investors Ownership
(%)		 Change
(%)
02-14 13G/A Ra Capital Management, L.p. 9.99 18.78
02-13 13G/A Janus Henderson Group Plc 7.30 16.86
02-13 13G/A Vanguard Group Inc 8.88 27.80
02-09 13G/A Fmr Llc 14.94 39.77
01-25 13G/A BlackRock Inc. 9.00 67.97

Top 13F Investors Shares
(1000)		 Change
(%)		 Value
($1000)		 Change
(%)

(click for more detail)

Date Insider Trades Code Shares Value

(click for more detail)

File Date Form SEC Filings
2024-02-27 10-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K
2023-11-06 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-Q
2023-08-08 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-Q
2023-05-08 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-Q

(click for more detail)
Short Volume
Market Date Short Volume Total Volume Short Volume Ratio
2024-04-29 50,170 368,114 13.63
2024-04-26 59,574 222,946 26.72
2024-04-25 136,142 362,626 37.54
2024-04-24 68,206 308,216 22.13

(click for more detail)

Similar Companies
PASG – Passage Bio, Inc. PBYI – Puma Biotechnology, Inc.
PCRX – Pacira BioSciences, Inc. PEPG – PepGen Inc.
PGEN – Precigen, Inc.


Financial data and stock pages provided by
Fintel.io